Acurx Pharmaceuticals, Inc. (ACXP) vs Lucyd, Inc (LUCY)

A side-by-side comparison of Acurx Pharmaceuticals, Inc. and Lucyd, Inc across valuation, profitability, dividends, and growth — built entirely from reported fundamentals, as of October 6, 2026. Differences are shown without an overall score or investment verdict.

Compare
Acurx Pharmaceuticals, Inc. logo
ACXP
Acurx Pharmaceuticals, Inc.
$6M
$1.30HealthcareDelayed quote: Oct 6, 2026, 11:01 AM EDT
Lucyd, Inc logo
LUCY
Lucyd, Inc
$6M
$0.92HealthcareDelayed quote: Oct 6, 2026, 11:05 AM EDT

Total return — ACXP vs LUCY

growth of $100 · dividends reinvested · last 4y
ACXP -98.5% (-65.3%/yr)LUCY -99.2% (-70.5%/yr)ACXP compounded faster over this window
050100Start $1002023202420252026$1$1
ACXP LUCY

ACXP vs LUCY: by the numbers

  • •LUCY is the larger company ($6M vs $6M market cap).
  • •Both run net losses; ACXP's is the smaller (0.00% vs -225.28% net margin).

Metrics side by side

Valuation

MetricACXPLUCY
P/S ratioN/A1.70
P/B ratio0.680.84

Profitability

MetricACXPLUCY
Gross margin0.00%22.79%
Operating margin0.00%-319.16%
Net margin0.00%-225.28%
ROE-92.08%-111.42%
ROIC-94.08%-122.15%

Growth (annualized)

MetricACXPLUCY
Revenue CAGR (5Y)N/A64.52%
Total return CAGR (5Y)-57.41%N/A

Go deeper

Full ACXP analysisFull LUCY analysisInteractive comparison tool

Dig into the metrics

Acurx Pharmaceuticals ROELucyd ROEAcurx Pharmaceuticals operating marginLucyd operating marginAcurx Pharmaceuticals revenue growthLucyd revenue growthAcurx Pharmaceuticals free cash flowLucyd free cash flow

Acurx Pharmaceuticals & Lucyd appear in these rankings

Fastest Revenue Growth Stocks

Figures are sourced from reported fundamentals and the latest end-of-day price. This comparison is informational only and is not investment advice. Past performance does not predict future results. See our methodology. Compiled by TGMCharts Research · data verified October 6, 2026.